New Crypto: Remittix Confirms November 24 RTX Launch as Ethereum Price Prediction Eyes $12,000 and Cardano’s Tokenized-Equity Push Revives the $1 ADA Dream

MAJURO, Marshall Islands, Oct. 11, 2026 (GLOBE NEWSWIRE) -- Remittix has confirmed November 24, 2026 as the scheduled market-launch date for RTX, placing a defined deadline on the final phase of a ...

First Tracks Biotherapeutics to Announce Top-Line Data from Cohort 1 of Phase 1b Trial of ANB033, a CD122 antagonist, in Celiac Disease on Oct. 12, 2026

First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX), a clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory ...

Acoramidis Associated with Significantly Improved Clinical Outcomes Versus Tafamidis in ATTR-CM in an Independent, Real-World Study of U.S. Electronic Health Records

In an independent, propensity score-matched analysis of 2,684 individuals living with ATTR-CM from Epic COSMOS, the largest U.S. electronic ...

Stellantis Unveils Six Concept Cars “The Night Before” the Paris Motor Show

Stellantis offered an exclusive preview of six of the nine concept cars set to debut at the Paris Motor Show, October 12-18 • Alfa ...

Crypto News: Remittix Opens PayFi to 1,000 Holders as Bitcoin Price Prediction Explodes to $200,000 and Solana’s 200ms Upgrade Fuels a $300 SOL Target

Remittix has opened PayFi access to 1,000 invited RTX holders, moving its crypto-to-bank payment platform into a hands-on ...

Freenome to Present New Validation Data for Next-Generation CRC Screening Test in Late-Breaking Oral Presentation at ACG 2026

Significant performance improvement seen across all subtypes of advanced precancerous lesions, which are important to detect for potential ...

BankStore.ai Maps Nearly 1,400 Banks and Payment Providers Into One Structured Dataset for Businesses

London, United Kingdom, October 11th, 2026, FinanceWireThe free catalogue lets businesses compare banks and payment ...

Claris Biotherapeutics Releases Positive CSB-001 Clinical Proof-of-Concept Data in Limbal Stem Cell Deficiency at AAO 2026 Annual Meeting

CSB-001 treated eyes gained≥15 letters compared to 0% in the non-treatment arm55% of CSB-001 treated eyes gained≥10 letters compared to 5% ...

Encaleret Increased Bone Turnover and Improved Participant-Reported Symptoms in the Phase 3 CALIBRATE Trial in ADH1

Encaleret administration increased bone turnover, based on its action to recover endogenous PTH secretion in patients with ADH1- 100% of ...

Cardurion Pharmaceuticals Presents Phase 2 Results for Tovinontrine (CRD-750), a PDE9 Inhibitor, as a Novel Treatment for Heart Failure

REF Phase 2 clinical trial, tovinontrine demonstrated substantial reduction in NT-proBNP, a biomarker for heart failure, in patients ...

RESONIKS Launches the First AI-Native Industrial Measurement Microphone

The MPK801: broadband, synchronized, and built for the factory floorNetherlands, October 11, 2026 -- RESONIKS, the AI ...

Beltone Asset Management and Amtaar Partner on a Multi-Issuance Real Estate Investment Fund with EGP 2 Billion in Targeted Issuances

Beltone Asset Management, a subsidiary of Beltone Holding, and Amtaar Capital have announced their partnership on a ...